Insights of nano drug delivery for cancer immunotherapy: Targeting tumor-associated macrophages in oral squamous cell carcinoma

Insights of nano drug delivery for cancer immunotherapy: Targeting tumor-associated macrophages in oral squamous cell carcinoma

Saved in:

Bibliographic Details
Main Authors:	Kalaiselvi Krishnamoorthy, Selvaraj Jayaraman, Vishnu Priya Veeraraghavan
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024001857
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Can vimentin be an emerging early detection molecular biomarker in oral squamous cell carcinoma?
by: Kalaiselvi Krishnamoorthy, et al.
Published: (2024-06-01)

Advancements in targeted drug delivery: A promising approach in oral cancer treatment
by: Rajkumar Prabhakaran, et al.
Published: (2024-06-01)

Emerging therapeutic targets in oral squamous cell carcinoma: Insights from genetic alterations
by: Santosh R. Patil, et al.
Published: (2024-06-01)

Targeted therapy: Role of liposome-based drug delivery in advancing oral cancer treatment
by: Meenakshi Sundari Rajendran, et al.
Published: (2024-06-01)

CD44: From diagnosis to therapy in the journey of oral cancer
by: Selvaraj Jayaraman, et al.
Published: (2024-06-01)

Bispecific T-cell engagers in oral cancer immunotherapy
by: Veeraraghavan Vishnu Priya
Published: (2024-06-01)

CDK5RAP2: A potential prognostication biomarker for oral squamous cell carcinoma?
by: Benson Paul, et al.
Published: (2024-06-01)

Revolutionizing precision medicine in oral squamous cell carcinoma: Harnessing 3D in vitro models for translation
by: Nitesh Buldak, et al.
Published: (2024-09-01)

Evaluation of exo-long noncoding RNA MALAT1 in OSCC in comparison to dysplastic and normal: A cross-sectional study
by: Ramya Sekar, et al.
Published: (2025-01-01)

Assessment of various etiological factors for oral squamous cell carcinoma in non-habit patients- a cross sectional case control study
by: Mudiyayirakkani Muthusamy, et al.
Published: (2025-01-01)

Expression of angiotensin converting enzyme 2 in patients with oral squamous cell carcinoma
by: Shivani Sivasakthivel, et al.
Published: (2024-06-01)

Osteopontin in oral squamous cell carcinoma: A multifaceted player in tumor development and prognosis
by: Hema Suryawanshi, et al.
Published: (2024-06-01)

Long non-coding RNA H19 in oral squamous cell carcinoma: A theragnostic approach using salivary exosomes
by: Ramya Sekar, et al.
Published: (2024-06-01)

Deciphering genomic complexity: Understanding intratumor heterogeneity, clonal evolution, and therapeutic vulnerabilities in oral squamous cell carcinoma
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-06-01)

Expression pattern of lncRNA H19 in oral squamous cell carcinoma tissues in comparison to normal tissues. A systematic review
by: Ramya Sekar, et al.
Published: (2025-03-01)

Recent development of micro-nano carriers for oral antineoplastic drug delivery
by: Hongzheng Li, et al.
Published: (2025-02-01)

Immunotherapy in oral cancer treatment: Harnessing the immune system to combat oral squamous cell carcinoma
by: Santosh R. Patil
Published: (2024-06-01)

Immunonutrition: A paradigm shift in oral cancer management
by: Vishnu Priya Veeraraghavan
Published: (2024-06-01)

Immunotherapy versus targeted therapy in management of recurrent squamous cell carcinoma of oral tongue
by: Nadimul Hoda, et al.
Published: (2024-06-01)

Promoting oral cancer awareness in LGBTQ+ communities - Diversity in oral health
by: Gayathri Rengasamy, et al.
Published: (2024-09-01)

Exploring the potential of bioluminescence in oral cancer
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-03-01)

ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
by: Saffron E. Summers, et al.
Published: (2023-03-01)

Oral microbiota dysbiosis and its association with oral squamous cell carcinoma: Implications for early detection and preventive strategies
by: Bharathi Selvaraj, et al.
Published: (2024-06-01)

Exosome mediated tailored therapy for oral cancer
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

Nuclear factor Erythroid 2-related factor (Nrf2): A potential therapeutic target for oral cancer - Molecular insights
by: Kaviyarasi Renu, et al.
Published: (2024-06-01)

Nanoengineered chemotherapy - A novel therapeutic strategy in oral cancer
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon
by: Prathiksha Srikanthan, et al.
Published: (2024-09-01)

NGS revolutionizing oral cancer: From genetic profiling to personalized therapy
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

Environmental pollution and its link to heightened oral cancer risk: A rapidly growing public health issue
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-06-01)

Anticancer effect of the antirheumatic drug leflunomide on oral squamous cell carcinoma by the inhibition of tumor angiogenesis
by: Chieko Niwata, et al.
Published: (2025-01-01)

Application of Nano-drug Delivery Technology in Overcoming Drug Resistance  in Lung Cancer
by: Yingchun LU, et al.
Published: (2024-11-01)

Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma
by: Ashok Patil, et al.
Published: (2015-01-01)

Exploring the Nanopore principle based portable device in oral cancer can serve as potential diagnostic tool facilitating focused treatment
by: Arthisri Anandhi Sekar, et al.
Published: (2024-03-01)

Perspective on enhancing quality of life in oral cancer patients: Integrative approaches and comprehensive care
by: Sohaib Arshad, et al.
Published: (2024-09-01)

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma
by: Angela J. Yoon, et al.
Published: (2025-01-01)

Advancements in personalized therapy for oral squamous cell carcinoma
by: Santosh R. Patil, et al.
Published: (2024-06-01)

(5E,7E)-4,5,6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5,7-dienoate from Euclea crispa (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms
by: Chella Perumal Palanisamy, et al.
Published: (2022-01-01)

Applications of cell penetrating peptide-based drug delivery system in immunotherapy
by: Jing-Jing Du, et al.
Published: (2025-01-01)

Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
by: Zhang Z, et al.
Published: (2025-01-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01)